Bjerkenstedt L., Edman G., Hagenfeldt L., Sedvall G., Wiesel F-A. (1985) Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls . Br J Psychiatr147: 276-282
2.
Bremer H.J., Duran M., Kamerling J.P., Przyrembel H., Wadman S.K. (1981) Disturbances of amino acid metabolism : clinical chemistry and diagnosis. Urban & Schwarzenberg, Baltimore
3.
Elsas L.J., II Trotter J.F. (1988) Changes in physiological concentrations of blood phenylalanine produce changes in sensitive parameters of human brain function . In Wurtman R J, Ritter-Walker E (eds), Dietary phenylalanine and brain function . Birkhauser, Boston, pp. 187-195
4.
Epstein C.M., Trotter J.F., Averbook A., Freeman S., Kutner M.H., Elsas L.J. (1989) EEG mean frequencies are sensitive indices of phenylalanine effects on normal brain. Electroencephalogr Clin Neurophysiol72: 133-139
5.
Gardos G., Cole J.O., Matthews J.D., Nierenberg A.A., Dugan S.J. (1992) The acute effects of a loading dose of phenylalanine in unipolar depressed patients with and without tardive dyskinesia. Neuropsychopharmacology6: 241-247
6.
Geddes J., Reynolds G., Rattenbury J.M., Peet M. ( 1992) The ratio of plasma phenylalanine to other large neutral amino acids is not a risk factor for tardive dyskinesia. J Psychopharmacol6: 278-280
7.
Hagenfeldt L., Bjerkenstedt L., Edman G., Sedvall G., Wiesel F-A. (1984) Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects. J Neurochem42: 833-837
8.
Pardridge W.M. (1986) Potential effects of the dipeptide sweetener aspartame on the brain. In Wurtman R J, Wurtman J J (eds), Nutrition and the brain . Vol 7. Raven Press, New York, pp. 199-241
9.
Rao M.L., Gross G., Strebel B., Braunig P., Huber G., Klosterkotter J. (1990) Serum amino acids, central monoamines, and hormones in drug-naive, drug-free, and neuroleptic-treated schizophrenic patients and healthy subjects. Psychiatr Res34: 243-257
10.
Richardson M.A., Haugland G., Pass R., Craig T.J. (1986) The prevalence of tardive dyskinesia in a mentally retarded population. Psychopharmacol Bull22: 243-249
11.
Richardson M.A., Suckow R., Whittaker R., Boggiano W., Sziraki I., Kushner H., Perumal A. (1989) The plasma phenylalanine/large neutral amino acid ratio. A risk factor for tardive dyskinesia. Psychopharmacol Bull25: 47-51
12.
Richardson M.A., Flynn C.J., Read L., Suckow R., Sziraki I., Kushner H., Boggiano W. (1992a) Amino acids, serotonin and TD remission. New York State Office of Mental Health Research Conference, Albany, December 7-9
13.
Richardson M.A., Flynn C.J., Read L., Suckow R., Sziraki I., Kushner H., Boggiano W. (1992b) Phenylalanine to serotonin to tardive dyskinesia: A new model. Proceedings of the 2nd International Symposium on Serotonin, from Cell Biology to Pharmacology and Therapeutics , Houston, September 15-18
14.
Richardson M.A., Flynn C.J., Read L., Suckow R., Sziraki I., Kushner H., Boggiano W. (1992c) PKU-like PHE metabolism is associated with tardive dyskinesia. Proceedings of the 5th International Amine Oxidase Meeting, Galway, Ireland August 24-27
15.
Wall K.M., Pardridge W.M. (1990) Decreases in brain protein synthesis elicited by moderate increases in plasma phenylalanine. Biochem Biophys Res Commun168: 1177-1183
